Xellia's delayed factory now up and running
2020 revenue at Xellia Pharmaceuticals, a part of the Novo group, took a beating from the delayed commissioning of its US factory. Now, however, the first batch of medication has left the building.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL FRANK CHRISTENSEN
After suffering from timing issues in inaugurating its factory in Cleveland, Ohio, Denmark's Xellia Pharmaceuticals has finally started production at its new facility, Xellia informs in a press statement after the firm shipped the first batch of antibiotics made at the plant, with sales directed at US hospitals.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Xellia pays steep price for factory delays
For subscribers
